<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37029410</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.</ArticleTitle><Pagination><StartPage>247</StartPage><MedlinePgn>247</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-023-04059-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">The clinical heterogeneity of SLE with its complex pathogenesis remains challenging as we strive to provide optimal management. The contribution of platelets to endovascular homeostasis, inflammation and immune regulation highlights their potential importance in SLE. Prior work from our group showed that the Fc&#x3b3; receptor type IIa (Fc&#x3b3;RIIa)-R/H131 biallelic polymorphism is associated with increased platelet activity and cardiovascular risk in SLE. The study was initiated to investigate the platelet transcriptome in patients with SLE and evaluate its association across Fc&#x3b3;RIIa genotypes and distinct clinical features.</AbstractText><AbstractText Label="METHODS">Fifty-one patients fulfilling established criteria for SLE (mean age&#x2009;=&#x2009;41.1&#x2009;&#xb1;&#x2009;12.3, 100% female, 45% Hispanic, 24% black, 22% Asian, 51% white, mean SLEDAI&#x2009;=&#x2009;4.4&#x2009;&#xb1;&#x2009;4.2 at baseline) were enrolled and compared with 18 demographically matched control samples. The FCGR2a receptor was genotyped for each sample, and RNA-seq was performed on isolated, leukocyte-depleted platelets. Transcriptomic data were used to create a modular landscape to explore the differences between SLE patients and controls and various clinical parameters in the context of FCGR2a genotypes.</AbstractText><AbstractText Label="RESULTS">There were 2290 differentially expressed genes enriched for pathways involved in interferon signaling, immune activation, and coagulation when comparing SLE samples vs controls. When analyzing patients with proteinuria, modules associated with oxidative phosphorylation and platelet activity were unexpectedly decreased. Furthermore, genes that were increased in SLE and in patients with proteinuria were enriched for immune effector processes, while genes increased in SLE but decreased in proteinuria were enriched for coagulation and cell adhesion. A low-binding FCG2Ra allele (R131) was associated with decreases in FCR activation, which further correlated with increases in platelet and immune activation pathways. Finally, we were able to create a transcriptomic signature of clinically active disease that performed significantly well in discerning SLE patients with active clinical disease form those with inactive clinical disease.</AbstractText><AbstractText Label="CONCLUSIONS">In aggregate, these data demonstrate the platelet transcriptome provides insight into lupus pathogenesis and disease activity, and shows potential use as means of assessing this complex disease using a liquid biopsy.</AbstractText><CopyrightInformation>&#xa9; 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cornwell</LastName><ForeName>MacIntosh G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Genetics, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannoudi</LastName><ForeName>Hanane El</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luttrell-Williams</LastName><ForeName>Elliot</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Tessa J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine, 530 First Avenue, Skirball 9R, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myndzar</LastName><ForeName>Khrystyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izmirly</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belmont</LastName><ForeName>H Michael</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clancy</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggles</LastName><ForeName>Kelly V</ForeName><Initials>KV</Initials><Identifier Source="ORCID">0000-0002-0152-0863</Identifier><AffiliationInfo><Affiliation>Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA. Kelly.ruggles@nyulangone.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Genetics, New York University Grossman School of Medicine, New York, NY, USA. Kelly.ruggles@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buyon</LastName><ForeName>Jill P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Grossman School of Medicine, Medical Science Building 593, 530 First Avenue, New York, NY, 10016, USA. jill.buyon@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA. jeffrey.berger@nyulangone.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine, 530 First Avenue, Skirball 9R, New York, NY, 10016, USA. jeffrey.berger@nyulangone.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35HL144993</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL139909</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM136573</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C445323">FCGR2A protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017452" MajorTopicYN="N">Receptors, IgG</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FCGR2a</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Lupus Nephritis</Keyword><Keyword MajorTopicYN="N">Platelet</Keyword><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Transcriptomics</Keyword></KeywordList><CoiStatement>Peter Izmirly has done scientific advisory boards for GSK (2/2019) and Momenta/Janssen (3/2021) Jill Buyon has done scientific advisory boards for GSK, Momenta/Janssen, BMS.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37029410</ArticleId><ArticleId IdType="pmc">PMC10082503</ArticleId><ArticleId IdType="doi">10.1186/s12967-023-04059-w</ArticleId><ArticleId IdType="pii">10.1186/s12967-023-04059-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145(5):408&#x2013;415. doi: 10.1093/oxfordjournals.aje.a009122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009122</ArticleId><ArticleId IdType="pubmed">9048514</ArticleId></ArticleIdList></Reference><Reference><Citation>Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331&#x2013;2337. doi: 10.1002/1529-0131(200110)44:10&lt;2331::AID-ART395&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2331::AID-ART395&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">11665973</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikpour M, Gladman DD, Iba&#xf1;ez D, Bruce IN, Burns RJ, Urowitz MB. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. J Rheumatol. 2009;36(2):288&#x2013;294. doi: 10.3899/jrheum.080776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080776</ArticleId><ArticleId IdType="pubmed">19208561</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399&#x2013;2406. doi: 10.1056/NEJMoa035471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa035471</ArticleId><ArticleId IdType="pubmed">14681505</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Iba&#xf1;ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142(12 Pt 1):953&#x2013;962. doi: 10.7326/0003-4819-142-12_Part_1-200506210-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-12_Part_1-200506210-00004</ArticleId><ArticleId IdType="pubmed">15968009</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanou A, James JA, Arriens C, Aberle T, Chakravarty E, Rawdon J, et al. Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures. Lupus Sci Med. 2019;6(1):e000365. doi: 10.1136/lupus-2019-000365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2019-000365</ArticleId><ArticleId IdType="pmc">PMC6937422</ArticleId><ArticleId IdType="pubmed">31921432</ArticleId></ArticleIdList></Reference><Reference><Citation>Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018;14(4):195&#x2013;213. doi: 10.1038/nrrheum.2018.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.38</ArticleId><ArticleId IdType="pubmed">29559714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, et al. Activated platelets induce endothelial cell activation via an interleukin-1&#x3b2; pathway in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol. 2017;37(4):707&#x2013;716. doi: 10.1161/ATVBAHA.116.308126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.116.308126</ArticleId><ArticleId IdType="pmc">PMC5597960</ArticleId><ArticleId IdType="pubmed">28153882</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001;115(2):451&#x2013;459. doi: 10.1046/j.1365-2141.2001.03101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2001.03101.x</ArticleId><ArticleId IdType="pubmed">11703349</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Schlegel M, Zhou F, Gorenchtein M, Bolstorff J, Moore KJ, et al. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci Transl Med. 2019 doi: 10.1126/scitranslmed.aax0481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax0481</ArticleId><ArticleId IdType="pmc">PMC6905432</ArticleId><ArticleId IdType="pubmed">31694925</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Cornwell M, Myndzar K, Rolling CC, Xia Y, Drenkova K, et al. Platelets amplify endotheliopathy in COVID-19. Sci Adv. 2021 doi: 10.1126/sciadv.abh2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh2434</ArticleId><ArticleId IdType="pmc">PMC8442885</ArticleId><ArticleId IdType="pubmed">34516880</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337&#x2013;351. doi: 10.1161/CIRCRESAHA.117.310795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310795</ArticleId><ArticleId IdType="pmc">PMC5777300</ArticleId><ArticleId IdType="pubmed">29348254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzaty Mirhashemi M, Shah RV, Kitchen RR, Rong J, Spahillari A, Pico AR, et al. The dynamic platelet transcriptome in obesity and weight loss. Arterioscler Thromb Vasc Biol. 2021;41(2):854&#x2013;864. doi: 10.1161/ATVBAHA.120.315186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315186</ArticleId><ArticleId IdType="pmc">PMC8105277</ArticleId><ArticleId IdType="pubmed">33297754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dann R, Hadi T, Montenont E, Boytard L, Alebrahim D, Feinstein J, et al. Platelet-derived MRP-14 induces monocyte activation in symptomatic peripheral artery disease. J Am Coll Cardiol. 2018;71(1):53&#x2013;65. doi: 10.1016/j.jacc.2017.10.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.072</ArticleId><ArticleId IdType="pmc">PMC5882198</ArticleId><ArticleId IdType="pubmed">29301628</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, et al. Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets. 2020;31(7):952&#x2013;959. doi: 10.1080/09537104.2020.1714573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1714573</ArticleId><ArticleId IdType="pmc">PMC7358121</ArticleId><ArticleId IdType="pubmed">31934818</ArticleId></ArticleIdList></Reference><Reference><Citation>Arman M, Krauel K. Human platelet IgG Fc receptor Fc&#x3b3;RIIA in immunity and thrombosis. J Thromb Haemost. 2015;13(6):893&#x2013;908. doi: 10.1111/jth.12905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12905</ArticleId><ArticleId IdType="pubmed">25900780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroupis C, Theodorou M, Chaidaroglou A, Dalamaga M, Oliveira SC, Cokkinos DV, et al. The association between a common FCGR2A polymorphism and C-reactive protein and coronary artery disease revisited. Genet Test Mol Biomarkers. 2010;14(6):839&#x2013;846. doi: 10.1089/gtmb.2010.0108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/gtmb.2010.0108</ArticleId><ArticleId IdType="pubmed">20973705</ArticleId></ArticleIdList></Reference><Reference><Citation>Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991;147(4):1338&#x2013;1343. doi: 10.4049/jimmunol.147.4.1338.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.147.4.1338</ArticleId><ArticleId IdType="pubmed">1831223</ArticleId></ArticleIdList></Reference><Reference><Citation>Melki I, Allaeys I, Tessandier N, Mailhot B, Cloutier N, Campbell RA, et al. Fc&#x3b3;RIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood. 2020;136(25):2933&#x2013;2945. doi: 10.1182/blood.2020004974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020004974</ArticleId><ArticleId IdType="pmc">PMC7751357</ArticleId><ArticleId IdType="pubmed">33331924</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy R, El Bannoudi H, Rasmussen SE, Bornkamp N, Allen N, Dann R, et al. Human low-affinity IgG receptor Fc&#x3b3;RIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus. J Thromb Haemost. 2019;17(3):532&#x2013;537. doi: 10.1111/jth.14385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14385</ArticleId><ArticleId IdType="pmc">PMC6440197</ArticleId><ArticleId IdType="pubmed">30638300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271&#x2013;1277. doi: 10.1002/art.1780251101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;2686. doi: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400&#x2013;1412. doi: 10.1002/art.40930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>igor. Seq-N-Slide: sequencing data analysis pipelines. 2021. https://github.com/igordot/sns</Citation></Reference><Reference><Citation>Andrews. Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</Citation></Reference><Reference><Citation>Wingett SW, Andrews S. FastQ screen: a tool for multi-genome mapping and quality control. F1000Res. 2018 doi: 10.1268/f1000research.15931.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1268/f1000research.15931.2</ArticleId><ArticleId IdType="pmc">PMC6124377</ArticleId><ArticleId IdType="pubmed">30254741</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard toolkit. Broad Institute, GitHub repository. Broad Institute; 2019. https://broadinstitute.github.io/picard/</Citation></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. ggplot2. In: Wickham H, editor. Elegant graphics for data analysis. New York: Springer; 2016.</Citation></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847&#x2013;2849. doi: 10.1093/bioinformatics/btw313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559. doi: 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS. 2005;102(43):15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integrat Biol. 2012;16(5):284&#x2013;287. doi: 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsd&#xf3;ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417&#x2013;425. doi: 10.1016/j.cels.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolgalev I. msigdbr: MSigDB Gene Sets for Multiple Organisms in a Tidy Data Format. 2019. https://CRAN.R-project.org/package=msigdbr</Citation></Reference><Reference><Citation>Foroutan M, Bhuva DD, Lyu R, Horan K, Cursons J, Davis MJ. Single sample scoring of molecular phenotypes. BMC Bioinformatics. 2018;19(1):404. doi: 10.1186/s12859-018-2435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-018-2435-4</ArticleId><ArticleId IdType="pmc">PMC6219008</ArticleId><ArticleId IdType="pubmed">30400809</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25&#x2013;29. doi: 10.1038/75556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Quek LS, Pasquet JM, Hers I, Cornall R, Knight G, Barnes M, et al. Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood. 2000;96(13):4246&#x2013;4253. doi: 10.1182/blood.V96.13.4246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V96.13.4246</ArticleId><ArticleId IdType="pubmed">11110698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson AA, R&#xf6;nnblom L. Role of interferons in SLE. Best Pract Res Clin Rheumatol. 2017;31(3):415&#x2013;428. doi: 10.1016/j.berh.2017.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2017.10.003</ArticleId><ArticleId IdType="pubmed">29224681</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med. 2019;6(1):e000270. doi: 10.1136/lupus-2018-000270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2018-000270</ArticleId><ArticleId IdType="pmc">PMC6703304</ArticleId><ArticleId IdType="pubmed">31497305</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK, Type I. Interferon in the pathogenesis of Lupus. J Immunol. 2014;192(12):5459&#x2013;5468. doi: 10.4049/jimmunol.1002795.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002795</ArticleId><ArticleId IdType="pmc">PMC4083591</ArticleId><ArticleId IdType="pubmed">24907379</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrianova IA, Khabirova AI, Ponomareva AA, Peshkova AD, Evtugina NG, Le Minh G, et al. Chronic immune platelet activation is followed by platelet refractoriness and impaired contractility. Int J Mol Sci. 2022;23(13):7336. doi: 10.3390/ijms23137336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137336</ArticleId><ArticleId IdType="pmc">PMC9266422</ArticleId><ArticleId IdType="pubmed">35806341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazilio AP, Viana VST, Toledo R, Woronik V, Bonf&#xe1; E, Monteiro RC. Fc&#x3b3;RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol Dial Transplant. 2004;19(6):1427&#x2013;1431. doi: 10.1093/ndt/gfh121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfh121</ArticleId><ArticleId IdType="pubmed">15004265</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest. 1996;97(5):1348&#x2013;1354. doi: 10.1172/JCI118552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118552</ArticleId><ArticleId IdType="pmc">PMC507190</ArticleId><ArticleId IdType="pubmed">8636449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>